The Optimal Timing of Restaging Resection before Introduction of Bacillus Calmette-Guerin Immunotherapy in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer. [electronic resource]
Producer: 20190329Description: 60-68 p. digitalISSN:- 1423-0399
- Aged
- BCG Vaccine -- therapeutic use
- Disease Progression
- Disease-Free Survival
- Female
- Follow-Up Studies
- Humans
- Immunotherapy -- methods
- Male
- Middle Aged
- Neoplasm Invasiveness
- Neoplasm Recurrence, Local
- Neoplasm Staging -- methods
- Retrospective Studies
- Risk
- Time Factors
- Urinary Bladder Neoplasms -- diagnosis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.